NCT04429620

Prospective Assay for SARS-CoV-2 (COVID-19) Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method

Prospective Assay for SARS-CoV-2 Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 100 (estimated)
• Sponsor: Szeged University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Prospective assay for SARS-CoV-2 antibody detection indirectly by immunofluorescence: SARS-CoV2 IIF method

Detailed description

Sample preparation, serum separation by centrifugation * 100 µl of serum for standard SARS-CoV2 ELISA is used according to the instructions for use. * 100 µl of serum indirect immunofluorescent (IIF) method is used, the samples thus prepared analysis is performed under an automated microscope

Conditions

• Sars-CoV2

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Immunfluorescence	Serum indirect immunofluorescent (IIF) method is used, analysis is performed under an automated microscope.

Timeline

• Start date: 2020-05-30
• Primary completion: 2020-12-31
• Completion: 2020-12-31
• First posted: 2020-06-12
• Last updated: 2020-06-25

Locations

1 site across 1 country: Hungary